{"id":1148,"date":"2021-06-29T15:45:11","date_gmt":"2021-06-29T06:15:11","guid":{"rendered":"http:\/\/blogs.flinders.edu.au\/mdri-news\/?p=1148"},"modified":"2021-06-29T15:45:11","modified_gmt":"2021-06-29T06:15:11","slug":"australian-researchers-to-conduct-world-first-sleep-disorder-diagnosis-evaluation-trial","status":"publish","type":"post","link":"https:\/\/blogs.flinders.edu.au\/mdri-news\/2021\/06\/29\/australian-researchers-to-conduct-world-first-sleep-disorder-diagnosis-evaluation-trial\/","title":{"rendered":"Australian researchers to conduct world-first sleep disorder diagnosis evaluation trial"},"content":{"rendered":"

Australian-based research and technology company Sleeptite<\/a>, has today announced its non-invasive sensor monitoring system, REMi<\/a>, will be used in a world-first sleep disorder diagnosis evaluation and monitoring trial.<\/p>\n

The REMi Sleep Diagnosis Evaluation Trial<\/strong><\/em> will be conducted in partnership with researchers from Flinders University and RMIT University and will see the REMi platform of invisible mattress sensors tested for their capability as a sleep disorder validation tool.
\n\"\"
\nSleeptite\u2019s REMi, launched in March<\/a>, has been designed to non-intrusively monitor aged care residents off the surface of a mattress providing insight into their presence, position, posture and sleep health status.<\/p>\n

The REMi platform will now be put to the test by experts from the Flinders Health and Medical Research Institute Sleep Health team at Flinders University in collaboration with the Functional Materials and Microsystems Research Group at RMIT.<\/p>\n

\u201cWhen we set out to develop REMi, our entire collaboration team knew we had a product that had the potential to provide sleep diagnostic information outside of an aged care setting,\u201d Sleeptite CEO Cameron van den Dungen said.<\/p>\n

\u201cWith a recent report from the Sleep Health Foundation and Deloitte showing 1 in 10 Australians suffer from a sleep disorder at a national economic cost of $14.4 billion there has never been a greater need for research in this space.<\/p>\n

\u201cI am so excited to see further scientific research show how the Sleeptite REMi platform can be used as a sleep diagnostic tool to determine sleep disorders such as sleep apnoea,\u201d he continued.<\/p>\n

The REMi Sleep Diagnosis Evaluation Trial,<\/em> conducted at Flinders University\u2019s Adelaide research centre, is expected to last six months and will include:<\/p>\n